GLP-1 receptor agonists affect more than glucose metabolismthey activate receptors throughout the brain involved in mood regulation and attention pathways
Semaglutide and cortisol regulation can help reduce stress-induced weight gain, making it easier to achieve sustainable weight loss results
Acta 120 MartenssonJ.LaiJ
doi: 10.3389/fnins.2013.00181 Received 31 May 2013 Accepted 20 September 2013 Published 14 October 2013 Volume 7 - 2013 Edited by Alfonso Abizaid, Carleton University, Canada Reviewed by Alfonso Abizaid, Carleton University, Canada
In this promising context, the likely availability in the near future of drugs for T2D at dosages equal to those used in obesity and with average weight reduction of 20% compared to baseline, such as tirzepatide 15 mg [77], oral semaglutide 50 mg [54], CagriSema 2.4/2.4 mg [82], will compellingly raise the issue of first-line treatment of patients with T2D, which should clearly be addressed to the fundamental pathogenetic moment of T2D, namely the increase in adiposity
But doctors may need to consider recommending exercise programs or develop other approaches, such as nutrition supplements or complementary medications, to help GLP-1 patients get the full cardiorespiratory benefits of substantial weight loss over the long-run, the researchers say